Graphite Bio
LENZ Therapeutics is is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision, focused on an eye drop to treat presbyopia and provide seamless vision for the vast majority of presbyopes.
Basic Information
- Category: Gene Editing
- Founded: 2019
- Headquarters: South San Francisco, CA
- Website: graphitebio.com
Evidence and Sources
- Graphite Bio — Official Site (official)
- Graphite Bio on linkedin (social)
Citation Guidance
Explore Gene Editing profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Graphite Bio.
- Canonical profile: https://brandsource.ai/brands/graphite-bio
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/graphite-bio/json-ld
- Citation profile API: https://brandsource.ai/api/brands/graphite-bio/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (78/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-28T04:26:06.232Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
LENZ Therapeutics is is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision, focused on an eye drop to treat presbyopia and provide seamless vision for the vast majority of presbyopes.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 supporting source linked.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.